Neocardon (Atenolol)

Atenolol, the active ingredient in Neocardon, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, relieve angina, and reduce the risk of cardiovascular events after a heart attack, primarily in adult patients.

GNH USA supplies Neocardon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution.

Neocardon (atenolol) is indicated for several cardiovascular conditions that involve excessive sympathetic activity.

- Hypertension: lowers systemic blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction prophylaxis: reduces the risk of recurrent ischemic events and improves survival. - Cardiac arrhythmias: helps control heart rate in certain supraventricular tachyarrhythmias.

Atenolol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue or tiredness. - Dizziness, especially when standing quickly. - Cold extremities such as hands and feet. - Bradycardia (slow heart rate). - Mild gastrointestinal upset (nausea, abdominal discomfort).

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Bronchospasm in patients with asthma or COPD. - Masking of hypoglycemia symptoms in diabetic patients. - Depression or mood changes. - Allergic reactions including rash, itching, or swelling.

Before initiating atenolol therapy, several safety considerations should be evaluated.

- Renal impairment: dose may need adjustment in patients with reduced kidney function. - Asthma or COPD: use with caution as β1‑selectivity may not fully prevent bronchospasm. - Diabetes: monitor blood glucose because atenolol can mask hypoglycemia symptoms. - Elderly: start at low dose and titrate slowly due to increased sensitivity. - Pregnancy: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Atenolol can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Non‑selective beta blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): risk of severe AV block. - Clonidine: abrupt withdrawal may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: enhanced hypotensive effect, monitor blood pressure. - Antidiabetic drugs: atenolol may mask hypoglycemia signs; adjust monitoring. - NSAIDs: may reduce antihypertensive efficacy of atenolol.